BioOptics Stock Watch
Markets
Stocks
Funds
Sectors
Tools
Current Price
Components
Dashboard
Latest News
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
BioOptics Stock Watch (CIX: BOSW)
4,483.05   +56.38 (+1.27%)
Streaming Delayed Price  /  Updated: 8:10 PM EDT, Jul 23, 2014  /  Add to My Watchlist      
View: Quote Components News
Index Value
Chart for (: )
 
Intraday
1 Week
1 Month
3 Month
1 Year
  
Compare to:
Price 4483.05
Volume 0
Open 4398.85
Prev. Close 4426.68
Change
+56.38
% Change
+1.27%
Today's Range 4393.18 - 4501.54
52wk Range 2458.56 - 4541.62
Performance
YTD
+1401.55 (45.48%)
1 Month
+164.83 (3.82%)
3 Month
+203.91 (4.77%)
6 Month
+1160.85 (34.94%)
1 Year
+1936.93 (76.07%)
Top News
More News
Spectranetics Announces FDA Clearance of Peripheral Laser Atherectomy Devices for In-Stent Restenosis
July 23, 2014
from GlobeNewswire News Releases
Investing in Medical Lasers
July 23, 2014
Lasers have been used in medical procedures since the late 1950's, and they're only getting more useful as time passes. Read More
from Wealth Daily
More News
More News
Tuesday’s Analyst Moves: Hasbro, Inc., Halliburton Company, Texas Instruments Incorporated, More (HAS, HAL, TXN, More)
July 22, 2014
Before Tuesday’s opening bell, a number of big name dividend stocks were the subject of analyst moves. Below, we highlight the important analyst commentary for investors. Barclays Upgrades Hasbro... Read More
from Dividend Daily
Cutera Appoints Miguel Pardos as Executive Vice President of International
July 22, 2014
from GlobeNewswire News Releases
Spectranetics (SPNC) Receives FDA 510(k) Clearance for ISR Products
July 23, 2014
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=9684299 for the full story. Read More
from StreetInsider.com News Articles
Spectranetics Announces FDA Clearance of Peripheral Laser Atherectomy Devices for In-Stent Restenosis
July 23, 2014
The Spectranetics Corporation (Nasdaq: SPNC) today announced receipt of U.S. Food and Drug Administration (FDA) 510(k) clearance of ... Read More
from Benzinga
OPKO Granted Patent from US Patent & Trademark Office for RAYALDEE
July 22, 2014
from Business Wire News Releases
Ackman's clients shrug off Herbalife embarrassment
July 23, 2014
Pershing Square Capital Management clients aren't very concerned about Herbalife's big gain yesterday. Read More
from CNBC.com News
OPKO Health (OPK), BioMarin (BMRN) Gain Following CNBC Mention
July 23, 2014
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=9683724 for the full story. Read More
from StreetInsider.com News Articles
BTIG: Valeant Must Sweeten Allergan Bid To More Than $200/Share
July 22, 2014
Allergan's (NYSE: AGN) strong showing in its recent second quarter suggests an acquirer may need to offer "north of $200 a ... Read More
from Benzinga
"OPKO Health, Inc. (OPK) - Product Pipeline Analysis, 2014 Update" Published
July 23, 2014
Boston, MA -- (SBWIRE) -- 07/23/2014 -- OPKO Health, Inc. (OPKO), formerly eXegenics, Inc., is a biopharmaceutical company. It discovers, develops, and commercializes novel diagnostic technologies and... Read More
from SBWire - Latest Press Releases
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here
toggle footer display